Latest News for: cd19

Edit

Anti CD19 monoclonal antibody UPLIZNAⓇ for I.V. Infusion 100mg Application for additional indication of immunoglobulin G4 related disease in Japan[PDF:435.6 KB] (Mitsubishi Tanabe Pharma Corporation)

Public Technologies 21 Mar 2025
Anti-CD19 monoclonal antibody UPLIZNAⓇ for I.V ... In IgG4- RD, CD19-expressing (CD19+) B cells are thought to drive inflammatory and fibrotic processes and interact with other immune cells that contribute to disease activity.
Edit

【Mitsubishi Tanabe Pharma】Anti CD19 monoclonal antibody UPLIZNA® for I.V. Infusion 100mg Application for additional indication of immunoglobulin G4 related disease in JapanNEW (Mitsubishi Chemical Group Corporation)

Public Technologies 21 Mar 2025
Anti-CD19 monoclonal antibody UPLIZNAⓇ for I.V ... In IgG4- RD, CD19-expressing (CD19+) B cells are thought to drive inflammatory and fibrotic processes and interact with other immune cells that contribute to disease activity.
  • 1
×